Preferred
(EDT)
Happening
Showing results 1 - 1 of 1
Tuesday, August 15, 2017
MS is an immune-mediated demyelinating disorder with a neurodegenerative component. While most of the current therapeutic approaches are immunomodulatory, there is a definite interest and urgent effort to identify novel treatments to promote myelin repair and restore function…
Moderators
Speaker Image
Bruce Bebo, PhD
National Multiple Sclerosis Society
Speaker Image
Patrizia Casaccia, MD, PhD
Icahn School of Medicine / Advanced Science Research Center at GC-CUNY
Panelists
Speaker Image
Dennis Bourdette, MD
Oregon Health & Science University
Speaker Image
Ari Green, MD
University of California, San Francisco
Speaker Image
Andrew Goodman, PhD
Yale School of Medicine
Speaker Image
Douglas Landsman, PhD
Associate Vice President, Biomedical Research, National Multiple Sclerosis Society
ePanel
neurobiology
neurobiology epanels
treatments
neurodegenerative diseases
multiple sclerosis
ePanel
Multiple Sclerosis
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.